PCM
PIII icon

Penserra Capital Management’s P3 Health Partners PIII Stock Holding History

Penserra Capital Management’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$9K – 1157
2022
Q2 		$9K Sell
50
-27
-35% -$7.52K ﹤0.01% 1282
2022
Q1 		$30K Sell
77
-62
-45% -$18.6K ﹤0.01% 1139
2021
Q4 		$49K Buy
139
+33
+31% +$15.7K ﹤0.01% 1025
2021
Q3 		$52K Buy
+106
New +$52.2K ﹤0.01% 1044

Other funds holding PIII

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Penserra Capital Management's PIII Position: Q3 2022 in Review

Penserra Capital Management sold out of P3 Health Partners (PIII) in Q3 2022, closing a stake of 50 shares — an estimated $9K sold.

Penserra Capital Management first reported a position in PIII in Q3 2021 and held it in 4 quarters. The position peaked at $52K in Q3 2021. 51 funds tracked by Wall St. Rank hold PIII as of Q3 2022.

  • Penserra Capital Management reported no remaining P3 Health Partners position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 50 P3 Health Partners shares in Q3 2022, an estimated $9K.
  • Penserra Capital Management first reported a position in P3 Health Partners in Q3 2021 and held it in 4 quarters.
  • Penserra Capital Management's P3 Health Partners position peaked at $52K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.